Literature DB >> 1481645

Vascular pseudoparkinsonism.

C M Chang1, Y L Yu, H K Ng, S Y Leung, K Y Fong.   

Abstract

Vascular pseudoparkinsonism may be confused with idiopathic Parkinson's disease. Patients may be unnecessarily treated with anti-parkinsonian drugs while their underlying vascular disease is ignored. We investigated 250 parkinsonian patients seen in our Movement Disorders Clinic for a possible vascular etiology. After excluding those with a known secondary cause such as drug-induced parkinsonism, progressive supranuclear palsy, multiple system atrophy and hyperparathyroidism, brain computed tomography and/or magnetic resonance imaging were performed on those who showed poor or no response to levodopa. In those with an ischemic lesion demonstrated on neuroimaging, anti-parkinsonian drugs were stopped and the patients were reassessed. Eleven patients (4.4%) had ischemic brain lesions accounting for their parkinsonism. All were initially diagnosed as Parkinson's disease because of the prominence of bradykinesia and rigidity. Gait disturbance was also common, but resting tremor was distinctly absent. Three anatomical patterns with different prognosis were identified. Three patients with basal ganglia lacunar infarct recovered spontaneously, three with frontal lobe infarcts remained static and five with periventricular and deep subcortical white matter lesions had progressive deterioration. Autopsy in one patient confirmed bilateral frontal lobe watershed infarcts and the absence of brain stem Lewy bodies. Parkinsonian patients with poor or no response to levodopa therapy should be investigated for a vascular etiology.

Entities:  

Mesh:

Year:  1992        PMID: 1481645     DOI: 10.1111/j.1600-0404.1992.tb05492.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  The L-dopa response in vascular parkinsonism.

Authors:  J C M Zijlmans; R Katzenschlager; S E Daniel; A J L Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

Review 2.  The neurobiology of falls.

Authors:  Alfonso Fasano; Meir Plotnik; Francesco Bove; Alfredo Berardelli
Journal:  Neurol Sci       Date:  2012-06-05       Impact factor: 3.307

3.  Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.

Authors:  Megan K Herbert; H Bea Kuiperij; Bastiaan R Bloem; Marcel M Verbeek
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

4.  Head tremor due to bilateral thalamic and midbrain infarction.

Authors:  S Otto; T Büttner; L Schöls; D T Windmeier; H Przuntek
Journal:  J Neurol       Date:  1995-09       Impact factor: 4.849

5.  Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism.

Authors:  L Rampello; A Alvano; G Battaglia; R Raffaele; I Vecchio; M Malaguarnera
Journal:  J Neurol       Date:  2005-06-06       Impact factor: 4.849

6.  Post-stroke movement disorders: report of 56 patients.

Authors:  F Alarcón; J C M Zijlmans; G Dueñas; N Cevallos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

7.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

8.  Subacute hemicorporal parkinsonism in 5 patients with infarcts of the basal ganglia.

Authors:  J Vaamonde; J M Flores; M J Gallardo; R Ibáñez
Journal:  J Neural Transm (Vienna)       Date:  2007-08-21       Impact factor: 3.575

9.  Parkinsonism and tremor disorders. A clinical approach.

Authors:  Hani Ts Benamer
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

Review 10.  Vascular Parkinsonism and cognitive impairment: literature review, Brazilian studies and case vignettes.

Authors:  Thiago Cardoso Vale; Maira Tonidandel Barbosa; Paulo Caramelli; Francisco Cardoso
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.